Since 2006 PolyCrystalLine collaborates with the Molecular Crystal Engineering (MCE) group at the Chemistry Department G. Ciamician of the Univer...
Read MoreIn less than a month we will take off to New York and take part to DCAT (Drug, Chemical & Associated Technologies Association) Week, a great...
Read MoreAre we going to be present at the next CPhI in Frankfurt? We are, of course! For three days, from November 1st to 3rd, we have the opportunity to reaf...
Read MoreABOUT THE CH@BO n.11 ONLINE CONVENTION Because of the uncertainties still associated with the pandemic of SARS-COVID-19 the 11th edition of the Bologn...
Read MoreNew Crystalline Forms of Des-Methyl-Venlafaxine Salt Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a gene...
Read MoreABSTRACT: The structure−property relationships of new polymorphs of the chiral herbicide imazamox were investigated by X-ray diffraction, hot s...
Read MoreWe invite you to join us at our booth n. 4H93 and learn more about our capabilities: Solid Form Development Crystallization Optimization Analytical Se...
Read MoreWe invite you to join us in our meeting room at the Intercontinental Suite #510/511 and learn more about our capabilities: Solid Form Development Crys...
Read MoreNew Crystalline Forms of Dex-Lansoprazole Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Kap...
Read MorePolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application. For additional information contact info@po...
Read More